1. Home
  2. ARRY vs SVRA Comparison

ARRY vs SVRA Comparison

Compare ARRY & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Array Technologies Inc.

ARRY

Array Technologies Inc.

N/A

Current Price

$7.01

Market Cap

1.1B

Sector

Technology

ML Signal

N/A

SVRA

Savara Inc.

N/A

Current Price

$5.53

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ARRY
SVRA
Founded
1989
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
2020
2009

Fundamental Metrics

Financial Performance
Metric
ARRY
SVRA
Price
$7.01
$5.53
Analyst Decision
Buy
Buy
Analyst Count
19
9
Target Price
$10.24
$7.33
AVG Volume (30 Days)
6.7M
1.3M
Earning Date
06-02-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
62.56
N/A
EPS
N/A
N/A
Revenue
$1,284,141,000.00
N/A
Revenue This Year
$16.03
N/A
Revenue Next Year
$7.79
N/A
P/E Ratio
N/A
N/A
Revenue Growth
40.22
N/A
52 Week Low
$3.76
$1.89
52 Week High
$12.23
$7.01

Technical Indicators

Market Signals
Indicator
ARRY
SVRA
Relative Strength Index (RSI) 30.92 47.05
Support Level $6.47 $5.47
Resistance Level $10.02 $6.10
Average True Range (ATR) 0.63 0.28
MACD -0.28 -0.02
Stochastic Oscillator 8.15 32.62

Price Performance

Historical Comparison
ARRY
SVRA

About ARRY Array Technologies Inc.

Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's segments include: the Array legacy operating segment (Array Legacy Operations) and the STI Operations operating segment (STI Operations). It derives maximum revenue from the Array legacy operating segment. Its product is an integrated system of steel supports, electric motors, gearboxes, and electronic controllers referred to as a single-axis tracker that moves solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Geographically, the company's operations are in the United States, Australia, Spain, Brazil, and the rest of the world, with the United States deriving the majority of the revenue.

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

Share on Social Networks: